Anne Mariucci
Taylor Morrison HomeAbout Anne L. Mariucci
Anne L. Mariucci, age 67, has served as an independent director of Taylor Morrison since March 2014, bringing 30+ years of homebuilding, real estate, capital markets, and M&A experience, including senior leadership at Del Webb and as President of Del Webb following its merger with Pulte Homes . She is General Partner of MFP (family office) since 2006 and holds a B.S. in accounting and finance (University of Arizona) and completed Stanford’s corporate finance program; she is designated by TMHC’s Board as an audit committee financial expert through her audit committee membership .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Del Webb Corporation | Senior management; led large-scale community development and homebuilding | Prior to 2003 | Operational leadership in large-scale developments |
| Del Webb (post-merger with Pulte Homes) | President | After merger with Pulte | Led integration and operations post-merger |
| MFP (family office) | General Partner | Since 2006 | Diversified investment oversight |
| Arizona State Retirement System | Director | Prior service | Pension oversight governance |
| Arizona Board of Regents | Past Chairman | Prior service | Higher education governance leadership |
| University of Arizona Health Network | Director | Prior service | Healthcare system oversight |
| Urban Land Institute | Trustee | Prior service | Industry best-practices/trustee role |
| Action Performance Companies | Director | Prior service | Public company governance |
External Roles
| Organization | Role | Committees | Status |
|---|---|---|---|
| Southwest Gas Holdings, Inc. | Director | Compensation; Nominating & Corporate Governance; Chair, Strategic Transaction Committee | Current |
| Centuri Group | Director | Chair, Nominating & Corporate Governance; member, Compensation | Current |
| Berry Corporation | Director | Chair, Compensation Committee | Current |
| CoreCivic | Director | Audit; Compensation; retiring at May 2025 annual meeting | Retiring May 2025 |
| Banner Health | Board Chair | — | Current |
| ASU Enterprise Partners | Director; Chairs ASU Endowment Investment Committee | — | Current |
Board Governance
- Independence: Determined independent under NYSE rules; serves on fully independent standing committees .
- Committee assignments: Chair, Compensation Committee; Member, Audit Committee .
- Audit financial expertise: Audit Committee members, including Mariucci, are financially literate and qualify as “audit committee financial experts” under SEC rules .
- Board and committee activity: Board met 6 times in 2024; Audit Committee met 9 times; Compensation Committee met 3 times; Nominating & Governance met 3 times .
- Attendance: No incumbent director attended fewer than 75% of aggregate Board and relevant committee meetings in 2024 .
- Leadership structure: Independent Lead Director framework; independent directors meet at least quarterly without management .
Fixed Compensation
| Component (2024) | Amount ($) | Notes |
|---|---|---|
| Base annual cash retainer | 85,000 | Standard non-employee director retainer |
| Compensation Committee Chair fee | 30,000 | Chair retainer |
| Audit Committee member fee | 12,000 | Member retainer |
| Total cash fees earned | 127,000 | Sum of cash components |
| Meeting fees | — | No meeting fees disclosed |
- Director fee schedule: Lead Independent Director +$40,000; Committee Chair fees: Audit $40,000, Compensation $30,000, Nominating & Governance $20,000; Members: Audit/Comp $12,000; Nom/Gov $10,000 .
Performance Compensation
| Grant | Grant Date | Instrument | Shares (#) | Price ($/sh) | Grant-Date Fair Value ($) | Vesting |
|---|---|---|---|---|---|---|
| Annual equity award | May 23, 2024 | RSUs | 3,075 | 56.91 | 174,998 | Vests in full on earlier of first anniversary or 2025 annual meeting (May 22, 2025) |
| Deferred stock units (balance) | As of Dec 31, 2024 | DSUs | 21,994 | — | — | DSUs settle in stock upon separation or change-in-control; no voting rights until settlement |
- Equity structure: Each non-employee director receives annual RSUs or elects DSUs with grant-date fair value $175,000; DSUs can also reflect deferred cash fees converted to share equivalents; director awards are service-vested (no performance metrics) .
Other Directorships & Interlocks
- Compensation Committee Interlocks: None; no members (including Chair Mariucci) had relationships requiring Item 404 disclosure; no reciprocal executive committee interlocks reported for 2024 .
- Over-boarding policy: Company maintains director over-boarding and mandatory retirement age 72 policies to manage workload and succession .
Expertise & Qualifications
- Homebuilding/Real Estate: Senior roles at Del Webb; President post-merger with Pulte; 30+ years sector experience .
- Finance & M&A: Capital markets and transactions experience; Stanford corporate finance program .
- Governance: Chairs TMHC Compensation; audit expertise; multiple public company committee leadership roles; Board Chair at Banner Health .
- Education: B.S. in accounting and finance (University of Arizona); Stanford corporate finance program .
Equity Ownership
| Metric | Value | Notes |
|---|---|---|
| Beneficial ownership (shares) | 95,104 | Includes family trust holdings; <1% of shares outstanding |
| Ownership % of outstanding | <1% | Based on 100,539,960 shares outstanding (Record Date) |
| RSUs outstanding (12/31/2024) | 3,075 | Scheduled to vest May 22, 2025 |
| DSUs outstanding (12/31/2024) | 21,994 | No voting rights until settlement |
| Shares held in family trust | 10,917 | Trustee role noted |
| Director stock retention policy | 5x annual base cash retainer | All non-employee directors met or are on track as of Dec 31, 2024 |
| Anti-hedging/shorting policy | Prohibits margin, shorts, options | Company-wide securities trading policy |
Governance Assessment
- Strengths: Independent status; Chair of Compensation Committee with use of independent consultant and strong pay-governance features; Audit Committee membership with financial expert designation; robust attendance and active committee cadence; director equity aligned via RSUs/DSUs; stock retention policy compliance; anti-hedging policy; no related-party transactions disclosed involving Mariucci .
- Shareholder sentiment signal: Say-on-pay support was 96.0% at the 2024 annual meeting, indicating broad investor approval of TMHC’s compensation program oversight (context for governance credibility) .
- Potential risk indicators: Multiple current public company directorships (SWX, Centuri, Berry, plus CoreCivic retiring) elevate time-commitment considerations; mitigated by TMHC’s over-boarding policy and her long tenure and committee leadership record .
- Conflicts and related-party: No related-person transactions requiring Item 404 disclosure; Audit Committee reviews any such transactions under formal policy .
Overall, Mariucci’s committee leadership (Compensation Chair; Audit member), independent designation, and sector expertise support board effectiveness and alignment. Absence of disclosed conflicts and adherence to stock retention and trading policies bolster investor confidence, while breadth of outside roles warrants routine monitoring against over-boarding thresholds .